This compound is primarily utilized in the field of medicinal chemistry and biochemistry, particularly in the development of nucleoside analogs. It serves as a key intermediate in the synthesis of antiviral and anticancer agents. Its structural modifications, such as the 7-deaza and 2',3'-dideoxy features, enhance its ability to inhibit viral replication by interfering with the viral polymerase activity. Researchers also employ it in studies focused on understanding the mechanisms of nucleotide incorporation and DNA/RNA synthesis. Additionally, its trifluoroacetyl (TFA) group aids in improving the stability and bioavailability of the compound during experimental applications.